Multiple Sclerosis Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014561081
Market Monitor Global
Oct-2021
Life Sciences
103 Pages

This report contains market size and forecasts of Multiple Sclerosis (MS) Drugs in global, including the following market information:
Global Multiple Sclerosis (MS) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Multiple Sclerosis (MS) Drugs Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Multiple Sclerosis (MS) Drugs companies in 2020 (%)
The global Multiple Sclerosis (MS) Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiple Sclerosis (MS) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Sclerosis (MS) Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multiple Sclerosis (MS) Drugs Market Segment Percentages, By Type, 2020 (%)
Copaxone (Glatiramer Acetate, Copolymer 1)
Novantrone (Mitoxantrone)
Gilenya (Fingolimod, Fty720)
Aubagio (Teriflunomide)
Tecfidera (Dimethyl Fumarate)
Firategrast (Sb683699, T-0047)
Siponimod (Baf312)
Others

Global Multiple Sclerosis (MS) Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multiple Sclerosis (MS) Drugs Market Segment Percentages, By Application, 2020 (%)
RRMS
SPMS
PPMS
PRMS

Global Multiple Sclerosis (MS) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multiple Sclerosis (MS) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Sclerosis (MS) Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Multiple Sclerosis (MS) Drugs revenues share in global market, 2020 (%)
Key companies Multiple Sclerosis (MS) Drugs sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Multiple Sclerosis (MS) Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Bayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Multiple Sclerosis (MS) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multiple Sclerosis (MS) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multiple Sclerosis (MS) Drugs Overall Market Size
2.1 Global Multiple Sclerosis (MS) Drugs Market Size: 2021 VS 2027
2.2 Global Multiple Sclerosis (MS) Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Multiple Sclerosis (MS) Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Multiple Sclerosis (MS) Drugs Players in Global Market
3.2 Top Global Multiple Sclerosis (MS) Drugs Companies Ranked by Revenue
3.3 Global Multiple Sclerosis (MS) Drugs Revenue by Companies
3.4 Global Multiple Sclerosis (MS) Drugs Sales by Companies
3.5 Global Multiple Sclerosis (MS) Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Multiple Sclerosis (MS) Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Multiple Sclerosis (MS) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multiple Sclerosis (MS) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Multiple Sclerosis (MS) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Multiple Sclerosis (MS) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Multiple Sclerosis (MS) Drugs Market Size Markets, 2021 & 2027
4.1.2 Copaxone (Glatiramer Acetate, Copolymer 1)
4.1.3 Novantrone (Mitoxantrone)
4.1.4 Gilenya (Fingolimod, Fty720)
4.1.5 Aubagio (Teriflunomide)
4.1.6 Tecfidera (Dimethyl Fumarate)
4.1.7 Firategrast (Sb683699, T-0047)
4.1.8 Siponimod (Baf312)
4.1.9 Others
4.2 By Type - Global Multiple Sclerosis (MS) Drugs Revenue & Forecasts
4.2.1 By Type - Global Multiple Sclerosis (MS) Drugs Revenue, 2016-2021
4.2.2 By Type - Global Multiple Sclerosis (MS) Drugs Revenue, 2022-2027
4.2.3 By Type - Global Multiple Sclerosis (MS) Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Multiple Sclerosis (MS) Drugs Sales & Forecasts
4.3.1 By Type - Global Multiple Sclerosis (MS) Drugs Sales, 2016-2021
4.3.2 By Type - Global Multiple Sclerosis (MS) Drugs Sales, 2022-2027
4.3.3 By Type - Global Multiple Sclerosis (MS) Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Multiple Sclerosis (MS) Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multiple Sclerosis (MS) Drugs Market Size, 2021 & 2027
5.1.2 RRMS
5.1.3 SPMS
5.1.4 PPMS
5.1.5 PRMS
5.2 By Application - Global Multiple Sclerosis (MS) Drugs Revenue & Forecasts
5.2.1 By Application - Global Multiple Sclerosis (MS) Drugs Revenue, 2016-2021
5.2.2 By Application - Global Multiple Sclerosis (MS) Drugs Revenue, 2022-2027
5.2.3 By Application - Global Multiple Sclerosis (MS) Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Multiple Sclerosis (MS) Drugs Sales & Forecasts
5.3.1 By Application - Global Multiple Sclerosis (MS) Drugs Sales, 2016-2021
5.3.2 By Application - Global Multiple Sclerosis (MS) Drugs Sales, 2022-2027
5.3.3 By Application - Global Multiple Sclerosis (MS) Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Multiple Sclerosis (MS) Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Multiple Sclerosis (MS) Drugs Market Size, 2021 & 2027
6.2 By Region - Global Multiple Sclerosis (MS) Drugs Revenue & Forecasts
6.2.1 By Region - Global Multiple Sclerosis (MS) Drugs Revenue, 2016-2021
6.2.2 By Region - Global Multiple Sclerosis (MS) Drugs Revenue, 2022-2027
6.2.3 By Region - Global Multiple Sclerosis (MS) Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Multiple Sclerosis (MS) Drugs Sales & Forecasts
6.3.1 By Region - Global Multiple Sclerosis (MS) Drugs Sales, 2016-2021
6.3.2 By Region - Global Multiple Sclerosis (MS) Drugs Sales, 2022-2027
6.3.3 By Region - Global Multiple Sclerosis (MS) Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Multiple Sclerosis (MS) Drugs Revenue, 2016-2027
6.4.2 By Country - North America Multiple Sclerosis (MS) Drugs Sales, 2016-2027
6.4.3 US Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.4.4 Canada Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.4.5 Mexico Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Multiple Sclerosis (MS) Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Multiple Sclerosis (MS) Drugs Sales, 2016-2027
6.5.3 Germany Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.4 France Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.5 U.K. Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.6 Italy Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.7 Russia Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.5.9 Benelux Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Multiple Sclerosis (MS) Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Multiple Sclerosis (MS) Drugs Sales, 2016-2027
6.6.3 China Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.6.4 Japan Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.6.5 South Korea Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.6.7 India Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Multiple Sclerosis (MS) Drugs Revenue, 2016-2027
6.7.2 By Country - South America Multiple Sclerosis (MS) Drugs Sales, 2016-2027
6.7.3 Brazil Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.7.4 Argentina Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Multiple Sclerosis (MS) Drugs Sales, 2016-2027
6.8.3 Turkey Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.8.4 Israel Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
6.8.6 UAE Multiple Sclerosis (MS) Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Corporate Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Multiple Sclerosis (MS) Drugs Major Product Offerings
7.1.4 Bayer AG Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Bayer AG Key News
7.2 Bayhill Therapeutics
7.2.1 Bayhill Therapeutics Corporate Summary
7.2.2 Bayhill Therapeutics Business Overview
7.2.3 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Major Product Offerings
7.2.4 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Bayhill Therapeutics Key News
7.3 Biogen Idec
7.3.1 Biogen Idec Corporate Summary
7.3.2 Biogen Idec Business Overview
7.3.3 Biogen Idec Multiple Sclerosis (MS) Drugs Major Product Offerings
7.3.4 Biogen Idec Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Biogen Idec Key News
7.4 Cinnagen
7.4.1 Cinnagen Corporate Summary
7.4.2 Cinnagen Business Overview
7.4.3 Cinnagen Multiple Sclerosis (MS) Drugs Major Product Offerings
7.4.4 Cinnagen Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Cinnagen Key News
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Corporate Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Major Product Offerings
7.5.4 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Daiichi Sankyo Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Multiple Sclerosis (MS) Drugs Major Product Offerings
7.6.4 Eli Lilly Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Eli Lilly Key News
7.7 Fast Forward Llc
7.7.1 Fast Forward Llc Corporate Summary
7.7.2 Fast Forward Llc Business Overview
7.7.3 Fast Forward Llc Multiple Sclerosis (MS) Drugs Major Product Offerings
7.4.4 Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Fast Forward Llc Key News
7.8 Antisense Therapeutics
7.8.1 Antisense Therapeutics Corporate Summary
7.8.2 Antisense Therapeutics Business Overview
7.8.3 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Major Product Offerings
7.8.4 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Antisense Therapeutics Key News
7.9 Apitope
7.9.1 Apitope Corporate Summary
7.9.2 Apitope Business Overview
7.9.3 Apitope Multiple Sclerosis (MS) Drugs Major Product Offerings
7.9.4 Apitope Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Apitope Key News
7.10 Five Prime Therapeutics
7.10.1 Five Prime Therapeutics Corporate Summary
7.10.2 Five Prime Therapeutics Business Overview
7.10.3 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Major Product Offerings
7.10.4 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Five Prime Therapeutics Key News
7.11 Genmab
7.11.1 Genmab Corporate Summary
7.11.2 Genmab Multiple Sclerosis (MS) Drugs Business Overview
7.11.3 Genmab Multiple Sclerosis (MS) Drugs Major Product Offerings
7.11.4 Genmab Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Genmab Key News
7.12 Artielle Immunotherapeutics
7.12.1 Artielle Immunotherapeutics Corporate Summary
7.12.2 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Business Overview
7.12.3 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Major Product Offerings
7.12.4 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Artielle Immunotherapeutics Key News
7.13 Genzyme
7.13.1 Genzyme Corporate Summary
7.13.2 Genzyme Multiple Sclerosis (MS) Drugs Business Overview
7.13.3 Genzyme Multiple Sclerosis (MS) Drugs Major Product Offerings
7.13.4 Genzyme Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Genzyme Key News
7.14 Glaxosmithkline
7.14.1 Glaxosmithkline Corporate Summary
7.14.2 Glaxosmithkline Business Overview
7.14.3 Glaxosmithkline Multiple Sclerosis (MS) Drugs Major Product Offerings
7.14.4 Glaxosmithkline Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.14.5 Glaxosmithkline Key News
7.15 Gw Pharmaceuticals
7.15.1 Gw Pharmaceuticals Corporate Summary
7.15.2 Gw Pharmaceuticals Business Overview
7.15.3 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Major Product Offerings
7.15.4 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Gw Pharmaceuticals Key News
7.16 Innate Immunotherapeutics
7.16.1 Innate Immunotherapeutics Corporate Summary
7.16.2 Innate Immunotherapeutics Business Overview
7.16.3 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Major Product Offerings
7.16.4 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Innate Immunotherapeutics Key News
8 Global Multiple Sclerosis (MS) Drugs Production Capacity, Analysis
8.1 Global Multiple Sclerosis (MS) Drugs Production Capacity, 2016-2027
8.2 Multiple Sclerosis (MS) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Multiple Sclerosis (MS) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multiple Sclerosis (MS) Drugs Supply Chain Analysis
10.1 Multiple Sclerosis (MS) Drugs Industry Value Chain
10.2 Multiple Sclerosis (MS) Drugs Upstream Market
10.3 Multiple Sclerosis (MS) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multiple Sclerosis (MS) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Multiple Sclerosis (MS) Drugs in Global Market
Table 2. Top Multiple Sclerosis (MS) Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Multiple Sclerosis (MS) Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Multiple Sclerosis (MS) Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Multiple Sclerosis (MS) Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Multiple Sclerosis (MS) Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Multiple Sclerosis (MS) Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Multiple Sclerosis (MS) Drugs Product Type
Table 9. List of Global Tier 1 Multiple Sclerosis (MS) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multiple Sclerosis (MS) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Bayer AG
Bayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE